Medical Oncology Partners (Tables)

3 Months Ended

Mar. 31, 2022

Medical Oncology Partners LLC [Member]

Schedule of Equity Method Investments [Line Items]

Equity Method Investment Summarized Financial Information

The following table presents the summarized financial information of MOP:

MOP Condensed Consolidated Income Statement Information

	Three Months Ended March 31,
	2022			2021
Patient revenue	$	533,000		$	537,000
Net loss	$	(188,000	)	$	(168,000	)
USNC’s equity in loss of MOP	$	(39,000	)	$	(60,000	)

MOP Condensed Consolidated Balance Sheet Information

	March 31, 2022			December 31, 2021
Current assets	$	277,000		$	201,000
Noncurrent assets		300,000			384,000
Total assets	$	577,000		$	585,000
Current liabilities	$	3,229,000		$	3,109,000
Noncurrent liabilities		78,000			92,000
Deficit		(2,730,000	)		(2,616,000	)
Total liabilities and deficit	$	577,000		$	585,000